Heartflow, the AI plaque analysis and FFR-CT incumbent, has once again taken the legal route to defend its cardiac CT ...

Functional decline and frailty in older heart failure patients can rapidly decrease their lifespan and it’s hard to quantify ...

Ladies and gents, it’s that time of year again where we take a look at MedAxiom’s Annual Cardiovascular Provider Compensation ...

The small list of cardiac imaging AI solutions to earn Medicare reimbursements just got bigger, following CMS’ move to add an OPPS code for AI-based coronary plaque assessments. That represents a ...

Antiplatelet medications and beta blockers can improve survival and quality of life for people with cardiovascular disease. But those protections may come with added risk on hot summer days. A study ...

One of imaging AI’s hottest segments just got even hotter with the completion of Us2.ai’s $15M Series A round and the global launch of its flagship echocardiography AI solution. It’s been at least a ...

A study in JAMA Cardiology found that broader genetic tests are better at identifying patients with cardiomyopathies and arrhythmias than disease-specific tests, despite perceived drawbacks. Currently ...

JACC released a special “almanac-style” issue highlighting the growing burden of cardiovascular disease worldwide. The Global Burden of Disease, Injuries, and Risk Factors study (GBD) is the world’s ...

Children born with congenital pulmonary valve disease no longer need repeat surgeries throughout childhood with the FDA approval of Edwards Lifesciences’ Autus Size-Adjustable Valve. Enter the Autus ...

Despite society guidelines and extensive clinical evidence demonstrating that traditional wire-based coronary physiology improves outcomes and reduces costs compared to angiography alone 1-2, ...

We are inching closer to a treatment for nonobstructive hypertrophic cardiomyopathy after Cytokinetics presented the full results from the ACACIA-HCM trial, showing that its cardiac myosin inhibitor, ...

It’s not often that a pair of studies completely challenges our assumptions in cardiology, but new data presented at HRS 2026 suggests myocardial infarction might not be the main cause of sudden ...